The anticonvulsant activity of a flavonoid-rich extract from orange juice involves both NMDA and GABA-benzodiazepine receptor complexes

Molecules

Volumn 21, Issue 9, 2016, Pages

  Citraro, Rita ^a   Navarra, Michele ^b   Leo, Antonio ^a   Di Paola, Eugenio Donato ^a   Santangelo, Ermenegildo ^a   Lippiello, Pellegrino ^c   Aiello, Rossana ^a   Russo, Emilio ^a   De Sarro, Giovambattista ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Absence epilepsy; Audiogenic seizures; Citrus sinensis; Complementary and alternative medicines; Flavonoids; Natural products; Orange; Orange juice; Spike wave discharges

Indexed keywords

EID: 84988941446     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21091261     Document Type: Article

References (43)

1. Sierra-Paredes, G.; Sierra-Marcuno, G. Extrasynaptic GABA and glutamate receptors in epilepsy. CNS Neurol. Disorders Drug Targets 2007, 6, 288-300.
2. Costello, D.J.; Delanty, N. Oxidative injury in epilepsy: Potential for antioxidant therapy? Exp. Rev. Neurother. 2004, 4, 541-553.
3. Obay, B.D.; Tasdemir, E.; Tumer, C.; Bilgin, H.; Atmaca, M. Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides 2008, 29, 448-455.
4. Wu, Z.; Xu, Q.; Zhang, L.; Kong, D.; Ma, R.; Wang, L. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem. Res. 2009, 34, 1393-1400.
5. Aguiar, C.C.; Almeida, A.B.; Araujo, P.V.; de Abreu, R.N.; Chaves, E.M.; do Vale, O.C.; Macedo, D.S.; Woods, D.J.; Fonteles, M.M.; Vasconcelos, S.M. Oxidative stress and epilepsy: Literature review. Oxid. Med. Cell. Longev. 2012, 2012, 795259.
6. Xu, K.; Stringer, J.L. Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizures. Epilepsy Behav. 2008, 13, 77-82.
7. Tome, A.R.; Feng, D.; Freitas, R.M. The effects of alpha-tocopherol on hippocampal oxidative stress prior to in pilocarpine-induced seizures. Neurochem. Res. 2010, 35, 580-587.
8. Hou, Y.; Aboukhatwa, M.A.; Lei, D.L.; Manaye, K.; Khan, I.; Luo, Y. Anti-depressant natural flavonols modulate bdnf and beta amyloid in neurons and hippocampus of double tgad mice. Neuropharmacology 2010, 58, 911-920.
9. Hanrahan, J.R.; Chebib, M.; Johnston, G.A. Flavonoid modulation of GABA(A) receptors. Br. J. Pharmacol. 2011, 163, 234-245.
10. Yao, L.H.; Jiang, Y.M.; Shi, J.; Tomas-Barberan, F.A.; Datta, N.; Singanusong, R.; Chen, S.S. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 2004, 59, 113-122.
11. Benavente-Garcia, O.; Castillo, J. Update on uses and properties of Citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 2008, 56, 6185-6205.
12. Grosso, G.; Galvano, F.; Mistretta, A.; Marventano, S.; Nolfo, F.; Calabrese, G.; Buscemi, S.; Drago, F.; Veronesi, U.; Scuderi, A. Red orange: Experimental models and epidemiological evidence of its benefits on human health. Oxida. Med. Cell. Longev. 2013, 2013, 157240.
13. Ferlazzo, N.; Visalli, G.; Smeriglio, A.; Cirmi, S.; Lombardo, G.E.; Campiglia, P.; Di Pietro, A.; Navarra, M. Flavonoid fraction of orange and bergamot juices protect human lung epithelial cells from hydrogen peroxide-induced oxidative stress. Evid. Based Compl. Alt. 2015, 2015, 957031.
14. 3+-induced oxidative stress. Environ. Toxicol. Pharmacol. 2016, 43, 248-256.
15. Celano, M.; Maggisano, V.; De Rose, R.F.; Bulotta, S.; Maiuolo, J.; Navarra, M.; Russo, D. Flavonoid fraction of Citrus reticulata juice reduces proliferation and migration of anaplastic thyroid carcinoma cells. Nutr. Cancer 2015, 67, 1183-1190.
16. Delle Monache, S.; Sanità, P.; Trapasso, E.; Ursino, M.R.; Dugo, P.; Russo, M.; Ferlazzo, N.; Calapai, G.; Angelucci, A.; Navarra, M. Mechanisms underlying the anti-tumoral effects of Citrus bergamia juice. PLoS ONE 2013, 8, e61484.
17. Ferlazzo, N.; Cirmi, S.; Russo, M.; Trapasso, E.; Ursino, M.R.; Lombardo, G.E.; Gangemi, S.; Calapai, G.; Navarra, M. NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells. Life Sci. 2016, 146, 81-91.
18. Navarra, M.; Ursino, M.R.; Ferlazzo, N.; Russo, M.; Schumacher, U.; Valentiner, U. Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models. Fitoterapia 2014, 95, 83-92.
19. Visalli, G.; Ferlazzo, N.; Cirmi, S.; Campiglia, P.; Gangemi, S.; Di Pietro, A.; Calapai, G.; Navarra, M. Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells. Anti-Cancer Agents Med. Chem. 2014, 14, 1402-1413.
20. Risitano, R.; Currò, M.; Cirmi, S.; Ferlazzo, N.; Campiglia, P.; Caccamo, D.; Ientile, R.; Navarra, M. Flavonoid fraction of bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes. PloS ONE 2014, 9, e107431.
21. Currò, M.; Risitano, R.; Ferlazzo, N.; Cirmi, S.; Gangemi, C.; Caccamo, D.; Ientile, R.; Navarra, M. Citrus bergamia juice extract attenuates β-amyloid-induced pro-inflammatory activation of THP-1 cells through MAPK and AP-1 pathways. Sci. Rep. 2016, 6, 20809.
22. Impellizzeri, D.; Bruschetta, G.; Di Paola, R.; Ahmad, A.; Campolo, M.; Cuzzocrea, S.; Esposito, E.; Navarra, M. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. Clin. Nutr. 2015, 34, 1146-1154.
23. Impellizzeri, D.; Cordaro, M.; Campolo, M.; Gugliandolo, E.; Esposito, E.; Benedetto, F.; Cuzzocrea, S.; Navarra, M. Anti-inflammatory and antioxidant effects of flavonoid-rich fraction of bergamot juice (BJe) in a mouse model of intestinal ischemia/reperfusion injury. Front. Pharmacol. 2016, 7, 203.
24. Cirmi, S.; Bisignano, C.; Mandalari, G.; Navarra, M. Anti-infective potential of citrus bergamia risso et poiteau (bergamot) derivatives: A systematic review. Phytother. Res. 2016, 30, 1404-1411.
25. Marino, A.; Paterniti, I.; Cordaro, M.; Morabito, R.; Campolo, M.; Navarra, M.; Esposito, E.; Cuzzocrea, S. Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis. Pharma. Nutr. 2015, 3, 53-59.
26. Kumar, A.; Lalitha, S.; Mishra, J. Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice. Epilepsy Behav. 2013, 29, 103-111.
27. Meldrum, B.S.; Rogawski, M.A. Molecular targets for antiepileptic drug development. Neurotherapeutics 2007, 4, 18-61.
28. De Sarro, G.; Carotti, A.; Campagna, F.; McKernan, R.; Rizzo, M.; Falconi, U.; Palluotto, F.; Giusti, P.; Rettore, C.; De Sarro, A. Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol-3(3H)-ones in mice. Pharmacol. Biochem. Behav. 2000, 65, 475-487.
29. Dingledine, R. Glutamatergic Mechanisms Related to Epilepsy: Ionotropic Receptors. In Jasper's Basic Mechanisms of the Epilepsies, 4th ed.; Noebels, J.L., Avoli, M., Rogawski, M.A., Olsen, R.W., Delgado-Escueta, A.V., Eds.; National Center for Biotechnology Information: Bethesda, MD, USA, 2012.
30. Citraro, R.; Russo, E.; Gratteri, S.; Di Paola, E.D.; Ibbadu, G.F.; Curinga, C.; Gitto, R.; Chimirri, A.; Donato, G.; De Sarro, G. Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology 2006, 51, 1058-1067.
31. Russo, E.; Gitto, R.; Citraro, R.; Chimirri, A.; De Sarro, G. New AMPA antagonists in epilepsy. Exp. Opin. Investig. Drugs 2012, 21, 1371-1389.
32. De Sarro, G.; Chimirri, A.; Meldrum, B.S. Group III mGlu receptor agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block. Eur. J. Pharmacol. 2002, 451, 55-61.
33. De Sarro, G.; Gratteri, S.; Naccari, F.; Pasculli, M.P.; De Sarro, A. Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice. Epilepsy Res. 2000, 40, 109-121.
34. Ferreri, G.; Chimirri, A.; Russo, E.; Gitto, R.; Gareri, P.; De Sarro, A.; De Sarro, G. Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents. Pharmacol. Biochem. Behav. 2004, 77, 85-94.
35. Watson, G.B.; Bolanowski, M.A.; Baganoff, M.P.; Deppeler, C.L.; Lanthorn, T.H. D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in xenopus oocytes. Brain Res. 1990, 510, 158-160.
36. Russo, E.; Scicchitano, F.; Citraro, R.; Aiello, R.; Camastra, C.; Mainardi, P.; Chimirri, S.; Perucca, E.; Donato, G.; De Sarro, G. Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. Neuroscience 2012, 226, 282-288.
37. De Sarro, G.; Ibbadu, G.F.; Marra, R.; Rotiroti, D.; Loiacono, A.; Donato Di Paola, E.; Russo, E. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. Neurosci. Res. 2004, 50, 37-44.
38. Russo, E.; Donato di Paola, E.; Gareri, P.; Siniscalchi, A.; Labate, A.; Gallelli, L.; Citraro, R.; De Sarro, G. Pharmacodynamic potentiation of antiepileptic drugs' effects by some hmg-coa reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol. Res. 2013, 70, 1-12.
39. Citraro, R.; Russo, E.; Ngomba, R.T.; Nicoletti, F.; Scicchitano, F.; Whalley, B.J.; Calignano, A.; De Sarro, G. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. Epilepsy Res. 2013, 106, 74-82.
40. Citraro, R.; Chimirri, S.; Aiello, R.; Gallelli, L.; Trimboli, F.; Britti, D.; De Sarro, G.; Russo, E. Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy. Epilepsia 2014, 55, 1284-1291.
41. Citraro, R.; Leo, A.; de Fazio, P.; De Sarro, G.; Russo, E. Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behavior in the wag/rij rat model of absence epilepsy. Br. J. Pharmacol. 2015, 172, 3177-3188.
42. Litchfield, J.T., Jr.; Wilcoxon, F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949, 96, 99-113.
43. De Sarro, G.; Paola, E.D.; Gratteri, S.; Gareri, P.; Rispoli, V.; Siniscalchi, A.; Tripepi, G.; Gallelli, L.; Citraro, R.; Russo, E. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in dba/2 mice. Pharmacol. Res. 2012, 65, 285-296.